Читать книгу Anti-Aging Therapeutics Volume XIII - A4M American Academy - Страница 5

A primary goal in prostate and other cancers is to identify aggressive cancers that can kill, as opposed to cancers that do not threaten life, and may not even show any symptoms. The current, widely-used diagnostic techniques make this identification extremely elusive. The technology to achieve this diagnostic distinction should be noninvasive, and provide measures that can be easily and accurately compared to previous exams, making it easy to track changes. At the same time, it should provide a systematic approach to monitoring the patient’s response to therapeutic intervention. In this way the diagnosis, monitoring and treatment can be tailored to each individual’s circumstances and responsiveness. With recent advances in the technology of Doppler ultrasound and MRI, these goals can and are being achieved. Now, advances in the computerization of the imaging, blood flow, and tumor measures of exact size and density, provide for an accurate and repeatable diagnosis, and a means to follow the individual’s unique pattern of cancer development, progress, and response to treatment. In this paper, the noninvasive diagnostic tracking of a patient’s progress is presented, along with a naturopathic nutritional approach, the Beta-Sitosterol/Antioxidant Matrix (B-Sit/AOX), which provides vital support for cell function and membrane integrity.

Keywords: prostate neoplasms, 3-D Doppler ultrasound, Gleason score, phytosterols, antioxidants, nutritional therapy